Feed JRI
JR

Nuveen Real Asset Income and Growth Fund

JRI · NYSE

$10.61 -0.38% (-$0.04)
1M -12.87%
Market Cap $291.2M
P/E Ratio 5.93x
Div. Yield 15.10%
ROE 12.38%

Bulios Fair Price

$8.52

19.7% downside

Current Price

$10.61

Undervalued Fair Value Overvalued

According to Bulios Fair Price, JRI is currently overvalued relative to its market price. How does it work?

Unlock fair price

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Analysis

An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.

Piotroski F-Score Moderate
6/9
Valuation
84 /100
Cheap
P/S 6.68x
P/B 0.79x
P/E 5.93x
Growth
61 /100
Stable
Book val. growth 0.49%
Rev. growth 38.21%
FCF growth N/A
Profitability
100 /100
Strong
Op. margin 131.91%
Net margin 112.64%
FCF margin N/A
Quality
89 /100
Excellent
ROA 9.03%
Asset turnover 0.08x
ROE 12.38%
Debt
100 /100
Low
Current ratio 4.75x
Int. coverage N/A
Net debt/EBITDA N/A
Stability
33 /100
Unstable
Rev. volatility 109.75%
EPS volatility 85.57%
Profitable years 3

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about JRI
Online

Sector

Financial Services

Industry

Asset Management - Income

CEO

John G. Wenker

Employees

-

Headquarters

Chicago

Upcoming events

15 OCT

Ex-Dividend

Ex-dividend date

8d
02 NOV

Dividend Payment

Payment date

26d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.